The BioMed X Institute
German research institute BioMed X and Ono Pharmaceutical, a Japanese pharmaceutical company, started a new joint research project on cancer immunotherapies.
HEIDELBERG, GERMANY / ACCESSWIRE / December 19, 2023 / BioMed X announced today a new joint research project with Ono Pharmaceutical Co., Ltd, marking the start of the collaboration between the German biomedical research institute and one of the largest pharmaceutical companies in Japan. The project entitled "New Strategies to Engage Neutrophils in Solid Tumors" will be hosted by the BioMed X Institute in Heidelberg, Germany. The goal of this research project is to design next-generation immunotherapies by leveraging the antitumor effects of neutrophils.
Developing immunotherapies that target T cells has proved highly effective, and it is still a rapidly evolving research area. However, many patients remain resistant to these therapies, necessitating the development of novel immunological strategies. The presence of neutrophils in solid tumors has been well-documented, albeit their role in the tumor microenvironment seems to be paradoxical according to the data accumulated thus far. By uncovering novel neutrophil biology, this project aims to leverage their functions to design novel immunotherapies.
The new research team will join nine other research groups at the BioMed X Institute in Heidelberg, Germany. Researchers who are interested in becoming part of this new research group are invited to respond to this international call for application by submitting a project proposal via the BioMed X Career Space at https://career.bio.mx/call/2023-BMX-C03 before February 18, 2024.
Christian Tidona, Founder and Managing Director of the BioMed X Institute: "Oncology and immunology, including tumor immunology, are key areas of expertise at BioMed X. We are proud and honored that Ono has chosen our institute to develop new strategies for engaging neutrophils in cancer therapy".
Toichi Takino, Senior Executive Officer/Executive Director, Discovery & Research at Ono Pharmaceutical: "We are very pleased to form a partnership with BioMed X in our mission dedicated to overcoming cancer. This innovative research collaboration will engage us with highly talented scientists around the world who possess unique ideas for immunotherapy utilizing neutrophils. We believe that the research team established through this collaboration will lead to the discovery of the next generation of immunotherapy with us".
About BioMed X
BioMed X is an independent research institute with sites in Heidelberg, Germany, New Haven, Connecticut, XSeed Labs in Ridgefield, Connecticut, and a worldwide network of partner locations. Together with our partners, we identify big biomedical research challenges and provide creative solutions by combining global crowdsourcing with local incubation of the world's brightest early-career research talents. Each of the highly diverse research teams at BioMed X has access to state-of-the-art research infrastructure and is continuously guided by experienced mentors from academia and industry. At BioMed X, we combine the best of two worlds - academia and industry - and enable breakthrough innovation by making biomedical research more efficient, more agile, and more fun.
About Ono
Ono Pharmaceutical Co., Ltd., headquartered in Osaka, Japan, is an R&D-oriented pharmaceutical company committed to creating innovative medicines in specific areas. Ono focuses its research on oncology, immunology, neurology and specialty research with high medical needs as priority areas for discovery and development of innovative medicines. For further information, please visit the company's website at https://www.ono-pharma.com/en.
Contact Information
Flavia-Bianca Cristian
Recruiting & Communications Manager
fbc@bio.mx
+49 6221 426 11 706
View the original press release on newswire.com.
SOURCE: BioMed X Institute
To view this piece of content from stats.newswire.com, please give your consent at the top of this page. To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Medical Components Specialists to Exhibit at Medical Technology Ireland 202519.9.2025 16:00:00 CEST | Press release
BELLINGHAM, MASSACHUSETTS / ACCESS Newswire / September 19, 2025 / Medical Components Specialists (MCS), a leading contract manufacturer of precision medical devices, announced its participation in the upcoming Medical Technology Ireland Expo and Conference, taking place September 24-25 at the Galway Racecourse. Medical Technology Ireland has become Europe's second-largest and fastest-growing medical device design event. This year, the conference is expected to draw more than 2,000 attendees and over 350 exhibitors, showcasing the latest innovations and solutions driving the Irish medtech sector. Over the course of two days, the conference program will feature sessions on topics including the future of Irish MedTech, unlocking global opportunities through innovation, the Women in MedTech Forum, and advancements in catheter technologies, among others. The event provides a platform for knowledge exchange, networking, and exploration of cutting-edge medical technologies shaping the global
Theometrics Global Partners With Acclaimed Designer Cristina Zavati to Launch 'MeaDea by Theo,' Championing Resilience at New York Fashion Week19.9.2025 15:00:00 CEST | Press release
NEW YORK CITY, NEW YORK / ACCESS Newswire / September 19, 2025 / Theometrics Global is proud to announce a new partnership with celebrated designer and founder of the renowned IELLELE brand, Cristina Zavati, to launch an exclusive new collection, "MeaDea by Theo." This collaboration, is a significant step in Theometrics' global mission to empower young creators, and will be officially unveiled during New York Fashion Week.'Magna Graecia Resurrected - Divine Femininity and Hellenic Design in Analipsi' Captured in Analipsi, Greece - an Ensemble of Crowned Beauty, Visionary Creators and Fashion Rooted in Ancient Legacy "As the world sees the glamour of Fashion Week on the world's biggest stage, let us recognize the blood, sweat, and tears that designers and models have to overcome," said Sotirios Hristos Stathopoulos (aka Sam Stathis). September is Suicide Awareness Month and Theometrics Global has consistently raised awareness for this cause, as it did in the 2023 fashion weeks in New Yo
Ondas Appoints Technologist and British Army Veteran Karl Eze as UK Strategic Advisor to Ondas Capital19.9.2025 14:40:00 CEST | Press release
Appointment strengthens Ondas Capital's presence in the United Kingdom to support technology and defense development initiatives Seasoned executive brings military, financial, and entrepreneurial experience to accelerate Ondas Capital's international strategy LONDON, UK / ACCESS Newswire / September 19, 2025 / Ondas Holdings Inc. (NASDAQ:ONDS) ("Ondas" or the "Company"), a leading provider of autonomous aerial and ground robot intelligence and private wireless solutions through its business units Ondas Autonomous Systems (OAS) and Ondas Networks, today announced that Karl Eze has been appointed as Strategic Advisor for the United Kingdom for Ondas Capital. Based in London, Mr. Eze will represent Ondas Capital, providing strategic insight into technology and defense markets, strengthening industry relationships, and supporting Ondas' mission to connect advanced technology, defense innovation, and global opportunities. "Ondas Capital is building a strong international platform," said Jam
Air Quality Solutions Launches the UK's Most Advanced Software for Air Quality Assessments19.9.2025 08:00:00 CEST | Press release
New cloud-based app helps Air Quality Consultants deliver Air Quality Assessments for planning applications 80% faster. NOTTINGHAM, UK / ACCESS Newswire / September 19, 2025 / Air Quality Solutions announces the launch of its ground-breaking Air Quality Software. This game-changing app enables air quality consultants to reliably complete assessments 80% faster and with higher accuracy. It boosts team productivity and reduces delivery costs.Air Quality Software User Interface "Air Quality Software has set a new standard," said Brendan McCormack, Founder of Air Quality Solutions. "Air Quality Assessments are now faster, easier, and more reliable than ever before. This software reflects years of hard work and we are excited to bring it to market. " Air Quality Solutions unveils exactly how Air Quality Software has transformed air quality assessments for planning: 1. More accurate methods Traditionally, air quality consultants manually measure or estimate critical data points such as vehic
Conga Hosts Premier European Customer Conference "Conga Connection EMEA 2025" in Paris18.9.2025 10:00:00 CEST | Press release
Leading B2B SaaS Company to Host More Than 150 Customers and Partners at Flagship EMEA Event October 8 LONDON, UK / ACCESS Newswire / September 18, 2025 / Conga, the market leader in AI-powered innovation in configure, price, quote (CPQ) and contract lifecycle management (CLM), and Document Automation, will host its flagship European customer conference, Conga Connection EMEA 2025, taking place October 8, at the prestigious Pullman Paris Tour Eiffel. The event is expected to attract more than 150 customers, partners, and industry leaders from across Europe for a day of learning, innovation, and networking focused on advancing business transformation and operational excellence. The conference will feature keynote presentations from Conga's executive leadership, including CEO Dave Osborne who will share Conga's strategic vision for empowering organizations to accelerate their journey to become a more connected, intelligent business, better able to minimize risk and maximize revenue. Cong
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom